Kanaph Therapeutics Grants Stock Options for 76,000 Shares to Three Employees

• Kanaph Therapeutics granted stock options over 76,000 common shares to three employees on Oct. 22, 2026.
• Options become exercisable in stages: 50% from Oct. 22, 2028, 25% from Oct. 22, 2029, and 25% from Oct. 22, 2030.
• All options expire on Oct. 21, 2035. Exercises will be settled through newly issued shares.
• The grant brings total stock options granted to 281,950 common shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kanaph Therapeutics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261022000298), on October 22, 2026, and is solely responsible for the information contained therein.